From the miRoncol archive: This historical update may contain promotional language or research findings that do not describe the current service. Retrospective research results do not establish prospective screening performance, and references to scientific prizes do not imply evaluation or endorsement of miRoncol or miCheckup. Do not rely on this archive for healthcare decisions; use the current product information and discuss screening decisions with a healthcare professional.
miRoncol established a Scientific Advisory Board in October 2023 to provide independent scientific and clinical perspective on its microRNA research and development program.
The announced board members included:
- Beth Rogozinski, CEO, Oncoustics
- Jiah Pearson-Leary, PhD, CEO, Spire Bio Advisory
- Vinona Bhatia, MD, MPH, Principal, Atapir
- Hallgeir Rui, MD, PhD, Professor, Thomas Jefferson University
- Jerry Lee, PhD, Professor, University of Southern California
Advisory-board participation does not constitute regulatory approval or a guarantee of product performance or clinical outcomes.